Group One Trading
SER icon

Group One Trading’s Serina Therapeutics SER Stock Holding History

Group One Trading’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-32
Closed -$5K – 5462
2019
Q1 		$5K Buy
32
+30
+1,500% +$4.39K ﹤0.01% 4450
2018
Q4 		$0 Buy
+2
New +$254 ﹤0.01% 5496

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Group One Trading's SER Position: Q2 2019 in Review

Group One Trading sold out of Serina Therapeutics (SER) in Q2 2019, closing a stake of 32 shares — an estimated $5K sold.

Group One Trading first reported a position in SER in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 51 funds tracked by Wall St. Rank hold SER as of Q2 2019.

  • Group One Trading reported no remaining Serina Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Group One Trading sold 32 Serina Therapeutics shares in Q2 2019, an estimated $5K.
  • Group One Trading first reported a position in Serina Therapeutics in Q4 2018 and held it in 2 quarters.
  • Group One Trading's Serina Therapeutics position peaked at $5K in Q1 2019.
  • 51 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2019.

Based on Group One Trading's 13F filing for Q2 2019, filed 9 Aug 2019.